LMNX · Defiance Daily Target 2x Long LMND ETF

-

Please sign in to comment on LMNX

1 Comment

Admin

4 years, 10 months ago

Luminex Corporation is currently in a long term uptrend where the price is trading 23.2% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.

Luminex Corporation's total revenue rose by 23.1% to $111M since the same quarter in the previous year.

Its net income has dropped by 92.9% to $239K since the same quarter in the previous year.

Finally, its free cash flow grew by 116.9% to $5M since the same quarter in the previous year.

Based on the above factors, Luminex Corporation gets an overall score of 4/5.

Sector	Healthcare
Exchange	NASDAQ
CurrencyCode	USD
ISIN	US55027E1029
Industry	Medical Instruments & Supplies

Market Cap	2B
PE Ratio	73.83
Target Price	37
Beta	nan
Dividend Yield	1.0%

ABOUT

Defiance Daily Target 2x Long LMND ETF

The fund is an actively managed exchange traded fund ("ETF") that attempts to achieve two times (200%) the daily percentage change in the share price of the Underlying Security by employing derivatives, namely swap agreements and/or listed options contracts. The fund manager has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the Underlying Security"s shares. The fund is non-diversified.

LMNX · Defiance Daily Target 2x Long LMND ETF

-

Defiance Daily Target 2x Long LMND ETF

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Defiance Daily Target 2x Long LMND ETF using a moving average strategy